Location of Repository

Deregulated Expression of the Human Tumor Marker CEA and CEA Family Member CEACAM6 Disrupts Tissue Architecture and Blocks Colonocyte Differentiation

By Christian Ilantzis, Luisa Demarte, Robert A. Screaton and Clifford P. Stanners

Abstract

Human carcinoembryonic antigen (CEA) and the CEA family member CEACAM6 (formerly nonspecific crossreacting antigen [NCA]) function in vitro, at least, as homotypic intercellular adhesion molecules and, in model systems, can block the terminal differentiation and anoikis of several different cell types. We have recently demonstrated that the increased cell surface levels of CEA and CEACAM6 in purified human colonocytes from freshly excised, well to poorly differentiated colon carcinomas are inversely correlated with the degree of cellular differentiation. Thus, deregulated expression of CEA/CEACAM6 could directly contribute to colon tumorigenesis by the inhibition of terminal differentiation and anoikis. Evidence against this view includes the common observation of increased CEA/ CEACAM6 expression as normal colonocytes differentiate in their migration up colonic crypt walls. We report here the direct effects of deregulated overexpression of CEA/CEACAM6, at levels observed in colorectal carcinomas, on the differentiation of two human colonic cell lines, SW-1222 and Caco-2. Stable transfectants of both of these cell lines that constitutively express 10- to 30-fold higher cell surface levels of CEA/CEACAM6 than endogenous levels failed to polarize and differentiate into glandular structures in monolayer or 31) culture or to form colonic crypts in a tissue architecture assay in nude mice. In addition, these transfectants were found to exhibit increased tumorigenicity in nude mice. These results thus support the contention that deregulated overexpression of CEA and CEACAM6 could provide a tumorigenic contribution to colon carcinogenesis

Topics: carcinoembryonic antigen, colon cancer, tissue architecture, colonocyte differentation, cell polarization, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Publisher: Elsevier
Year: 2002
DOI identifier: 10.1038/sj.neo.7900201
OAI identifier: oai:doaj.org/article:e5bf7ecb310f4eec8862c3f35815a8f8
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1522-8002 (external link)
  • https://doaj.org/toc/1476-5586 (external link)
  • http://www.sciencedirect.com/s... (external link)
  • https://doaj.org/article/e5bf7... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.